Výsledky vyhledávání

Akademický článek

The number needed to treat and relevant between-trial comparisons of competing interventions

Autor: Jansen JP, Khalid JM, Smyth MD, Patel H

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 865-871 (2018)

Jeroen P Jansen,1 Javaria Mona Khalid,2 Michael D Smyth,3 Haridarshan Patel4 1Evidence Synthesis and Decision Modeling, Precision Xtract, Oakland, CA, USA; 2Evidence and Value Generation, Takeda International – UK Branch, London, UK; 3Global Medica

Externí odkaz: https://doaj.org/article/c7015710aa394c028c2834d65a2231cf

Zobrazit plný text záznamu

Akademický článek

Incorporating alternative design clinical trials in network meta-analyses

Autor: Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ

Publikováno v: Clinical Epidemiology, Vol 2015, Iss default, Pp 29-35 (2014)

Kristian Thorlund,1–3 Eric Druyts,1,4 Kabirraaj Toor,1,5 Jeroen P Jansen,1,6 Edward J Mills1,3 1Redwood Outcomes, Vancouver, BC, 2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 3Stanford Prevention

Externí odkaz: https://doaj.org/article/7125ef3add2847a58351cc61f4ff263d

Zobrazit plný text záznamu

Akademický článek

Efficacy of indacaterol 75 µg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis

Autor: Cope S, Kraemer M, Zhang J, Capkun-Niggli G, Jansen JP

Publikováno v: International Journal of COPD, Vol 2012, Iss default, Pp 415-420 (2012)

Shannon Cope,1 Matthias Kraemer,2 Jie Zhang,3 Gorana Capkun-Niggli,2 Jeroen P Jansen11MAPI Consultancy, Boston, MA, USA; 2Novartis Pharmaceuticals, Basel, Switzerland; 3Novartis Pharmaceuticals, East Hanover, NJ, USABackground: The purpose of this st

Externí odkaz: https://doaj.org/article/86519865b69940d188258e2bba8b8ca8

Zobrazit plný text záznamu

Akademický článek

Comparative efficacy of indacaterol 150 µg and 300 µg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysis

Autor: Cope S, Capkun-Niggli G, Gale R, Jardim JR, Jansen JP

Publikováno v: International Journal of COPD, Vol 2011, Iss default, Pp 329-344 (2011)

Shannon Cope1, Gorana Capkun-Niggli2, Rupert Gale3, José R Jardim4, Jeroen P Jansen11Mapi Values, Boston, MA, USA; 2Health Economics and Outcomes Research, Novartis Pharma AG, Basel, Switzerland; 3Novartis Horsham Research Centre, Horsham, UK; 4Resp

Externí odkaz: https://doaj.org/article/3573f86855694c25b9b59fec2866e91f

Zobrazit plný text záznamu

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

Autor: Dario Kringel, Ilias W, Jörn Lötsch, Eduard Resch, Alfred Ultsch, Michael Zimmermann, Andreas Kopf, Rainer Freynhagen, Alexandra Doehring, Norbert Griessinger, Jansen Jp, Christoph Stein

Publikováno v: The Pharmacogenomics Journal

Next-generation sequencing (NGS) provides unrestricted access to the genome, but it produces ‘big data’ exceeding in amount and complexity the classical analytical approaches. We introduce a bioinformatics-based classifying biomarker that uses em

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd61ece5c9949ba82115e31ad928bbce
https://doi.org/10.1038/tpj.2016.28

Zobrazit plný text záznamu